Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006525 |
YEM_ID: | YEM-1021 |
ID: | TCMBANKHE006525/YEM-1021 |
植物拉丁名: |
|
功能与主治: | To clear heat and disinhibit damp, stanch bleeding and engender flesh, resolve toxin and disperse swelling./Diarrhea, dysentery, jaundice, strangury syndrome, edema, coughing of blood, hematuria, hematochezia, bleeding knife wound, painful swelling from knocks and falls, sore and welling abscess, burns and scalds. |
药用植物名: | 凤尾蕨 |
药名: | 凤尾草 |
来源: | 云南民族药物志：第五卷 |
药用部位: | whole herb |
使用民族: | 傣族/傈僳族 |
TCM_ID_id: | 3189 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN011234 | Notholaenic acid | C17H18O5 | 302.32 g/mol | COC1=CC=C(C=C1)CCC2=C(C(=CC(=C2)OC)O)C(=O)O | |
| TCMBANKIN012111 | creticoside A-B | ||||
| TCMBANKIN014106 | Isonotholaenic acid | C17H18O5 | 302.32 g/mol | COC1=CC=C(C=C1)CCC2=C(C(=CC(=C2)O)OC)C(=O)O | |
| TCMBANKIN016306 | substanz D | ||||
| TCMBANKIN018051 | Flavokawin B | C17H16O4 | 284.31 g/mol | COC1=CC(=C(C(=C1)OC)C(=O)C=CC2=CC=CC=C2)O | |
| TCMBANKIN022056 | 17-Dihydroxy-3-oxo-ent-kaurane | ||||
| TCMBANKIN023802 | Triangularin | C17H16O4 | 284.31 g/mol | CC1=C(C=C(C(=C1O)C(=O)C=CC2=CC=CC=C2)O)OC | |
| TCMBANKIN026833 | substanz B | ||||
| TCMBANKIN027111 | substanz A | ||||
| TCMBANKIN030466 | creticosid A | ||||
| TCMBANKIN033497 | 6α,10,12-trihydroxypicrotoxane | ||||
| TCMBANKIN036888 | Pinocembrin | Spectrum5_000349; KBio3_002549; AIDS014893; (R)-5,7-Dihydroxy-2-phenylchroman-4-one; NCGC00017205-02; SDCCGMLS-0066749.P001; ZB000598; SpecPlus_000896; (-)-pinocembrin; pinocembrine; (2S)-5,7-dihydroxy-2-phenyl-4-chromanone; Spectrum_001879; AKOS030254805; KBio2_004969; URFCJEUYXNAHFI-CYBMUJFWSA-N; NCGC00017205-01; Spectrum3_001635; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (S)-(-)-; ST023293; 5,7-Dihydroxyflavanone; BSPBio_003329; ZINC00073693; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (2R)-; (S)-2,3-Dihydro-5,7-dihydroxy-2-phenyl-4H-1-benzopyran-4-one; AK582703; 206660-42-6; KBio2_007537; NCGC00142377-01; (2S)-5,7-dihydroxy-2-phenylchroman-4-one; TNP00071; Pinocembrin (6CI); NSC 279005; (2R)-5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one; SCHEMBL10080882; Oprea1_508274; (R)-PINOCEMBRIN; DivK1c_006992; (2R)-5,7-dihydroxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one; A836234; SPBio_001859; Spectrum2_001670; AIDS-014893; KBioSS_002406; KBio2_002401; CTK0J0172; AC1LDIB9; (2R)-5,7-bis(oxidanyl)-2-phenyl-2,3-dihydrochromen-4-one; N2094; NSC 661207; (2R)-5,7-dihydroxy-2-phenylchroman-4-one; ZINC4935; BDBM26666; 480-39-7; KBioGR_002249; DTXSID30349853; CHEMBL399249; pinocembrin; ST024705; C09827; KBio1_001936; (R)-5,7-dihydroxyflavanone; (2S)-5,7-dihydroxy-2-phenyl-chroman-4-one; (2R)-5,7-DIHYDROXY-2-PHENYL-2,3-DIHYDRO-1-BENZOPYRAN-4-ONE; NSC 43318; Spectrum4_001765 | C16H14O4 | 270.28 | c1([H])c([H])c([H])c([C@@]2([H])Oc(c([H])c(C([H])([H])O[H])c([H])c3O[H])c3C(=O)C2([H])[H])c([H])c1[H] |
| TCMBANKIN040417 | Ptaquiloside | 398.45 | |||
| TCMBANKIN042858 | Luteolin | Prestwick3_000870; TNP00073; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-); 62696_FLUKA; ACon1_000223; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; Digitoflavone; SMR000326896; luteolin-7-olate anion; 4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; CHEBI:57545; FLAVONE, 3',4',5,7-TETRAHYDROXY-; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone; A827664; BPBio1_001011; MEGxp0_000143; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy- (9CI); Weld Lake; BSPBio_000919; CHEBI:15864; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; Oprea1_849964; Yama kariyasu; 4-[5,7-bis(oxidanyl)-4-oxidanylidene-chromen-2-yl]-2-oxidanyl-phenolate; ST024703; luteolin ; NCGC00016467-02; EINECS 207-741-0; AIDS001406; NCGC00142375-02; C.I. Natural Yellow 2; S00110; Luteoline; Luteolin; Luteolol; 3′,4′,5,7-Tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; Prestwick_122; 5,7,3',4'-Tetrahydroxyflavone; BRN 0292084; CAS-491-70-3; 4-(5,7-dihydroxy-4-oxo-1-benzopyran-2-yl)-2-hydroxyphenolate; ZINC00008613; NCGC00142375-01; Prestwick1_000870; AIDS-001406; C01514; CCRIS 3790; 3',4',5,7-Tetrahydroxyflavone; Flacitran; Cyanidenon 1470; MLS000697655; SPBio_002840; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; Lopac0_000660; NCGC00016467-01; C.I. 75590; Prestwick0_000870; 491-70-3; 2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-oxylato-4H-1-benzopyran-4-one; 5-18-05-00296 (Beilstein Handbook Reference); Prestwick2_000870; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; L9283_SIGMA; 3′,4′,5,7-Tetrahydroxyflavone; SMP2_000042; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromone | C15H10O6 | 286.236 | c1(O[H])c([H])c(OC(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C([H])C3=O)c3c(O[H])c1[H] |
| TCMBANKIN044850 | Pterosin S | CHEMBL1864404; HMS2205M21; pterosin s; MLS002473105; 56227-00-0; SMR001397207 | 250.29 g/mol | ||
| TCMBANKIN058233 | aromadendrol | A827424; dihydrokaempferol; (2R,3R)-3,5-dihydroxy-2-(4-hydroxyphenyl)-4-oxochroman-7-olate; (2R,3R)-3,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-5-olate; (2R,3R)-2-(4-hydroxyphenyl)-3,7-bis(oxidanyl)-4-oxidanylidene-2,3-dihydrochromen-5-olate; (+)-dihydrokaempferol 7-oxoanion; CHEBI:57294 | C15H12O6 | 288.25 g/mol | C1=CC(=CC=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN058247 | Phloretol | Phloretin; EU-0101012; Dihydronaringenin; KBioGR_001803; 3-(4-Hydroxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-one; CCRIS 7459; BCBcMAP01_000040; SDCCGMLS-0066637.P001; .beta.-(p-Hydroxyphenyl)phloropropiophenone; SMP1_000238; 79310_FLUKA; NCGC00094304-03; AIDS-052153; 2',4',6'-Trihydroxy-3-(p-hydroxyphenyl)propiophenone; Propiophenone, 2',4',6'-trihydroxy-3-(p-hydroxyphenyl)- (8CI); DivK1c_006429; KBioSS_001775; NSC 407292; CHEBI:17276; KBio3_002071; EINECS 200-488-7; KBio2_006911; P7912_SIGMA; AIDS052153; KBio1_001373; Spectrum3_001036; 2',4',6'-Trihydroxy-3-(4-Hydroxyphenyl)propiophenone; beta-(4-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone; Spectrum5_001698; 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanone; Lopac0_001012; Spectrum2_000681; Lopac-P-7912; NCGC00015840-01; beta-(p-Hydroxyphenyl)phloropropiophenone; SMR000326783; G50; 3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one; SPECTRUM300554; 2′,4′,6′-Trihydroxy-3-(4-hydroxyphenyl)propiophenone; beta-(p-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone; MLS000728507; KBio2_004343; Propiophenone, 2',4',6'-trihydroxy-3-(p-hydroxyphenyl)-; Oprea1_824722; TNP00255; 60-82-2; SpecPlus_000333; NCGC00015840-02; 2′,4′,6′-Trihydroxy-3-p-hydroxyphenylpropiophenone; ST057164; BSPBio_002851; KBio2_001775; NCGC00094304-02; C00774; ZINC00047553; SPBio_000801; Spectrum_001295; 1-Propanone, 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-; Spectrum4_001172; NSC407292; .beta.-(p-Hydroxyphenyl)-2,4,6-trihydroxypropiophenone; phloretin | C15H14O5 | 274.27 g/mol | C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O)O)O)O |
| TCMBANKIN058319 | chrysin | NCI60_003886; AIDS-001398; NCGC00094842-05; Spectrum5_001503; 5,7-dihydroxy-2-phenyl-chromen-4-one; 5,7-dihydroxy-2-phenyl-4H-chromen-4-one; CAS-480-40-0; AIDS001398; Spectrum3_001399; KBio3_002238; 5,7-dihydroxy-2-phenylchromen-4-one; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl- (9CI); NCGC00094842-04; 5,7-dihydroxy-2-phenyl-4-chromenone; BPBio1_000746; SPBio_000766; 5-18-04-00076 (Beilstein Handbook Reference); SPBio_002897; SBB012459; KBioSS_000725; SPECTRUM1500709; BSPBio_003018; KBio2_000725; chrysin ; Prestwick2_000889; 5,7-dihydroxyflavone; Spectrum4_000780; FLAVONE, 5,7-DIHYDROXY-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-phenyl-; Spectrum_000245; Spectrum2_000753; KBio2_003293; 5,7-diOH-Flavone; SDCCGMLS-0066586.P001; KBio1_000614; NCGC00016456-01; SPECTRUM1505144; IDI1_000614; EINECS 207-549-7; Oprea1_045160; SMP1_000070; Prestwick3_000889; Chrysine; KBio2_005861; Prestwick1_000889; 5,7-Dihydroxy-2-phenyl-4H-benzo(b)pyran-4-one; S00112; NCGC00094842-01; NCGC00094842-03; MEGxp0_001416; C80105_ALDRICH; DivK1c_000614; 5,7-dihydroxy-2-phenyl-chromone; KBioGR_001200; NCGC00094842-02; 5,7-Dihydroxyflavone; NINDS_000614; BSPBio_002514; 5,7-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one; ZINC00057650; 480-40-0; ACon1_000087; 27214_FLUKA; C10028; NSC 407436; BRN 0233276; Prestwick0_000889; NSC407436; BSPBio_000678; Chrysin; 5,7-dihydroxyflavone | C15H10O4 | 254.24 g/mol | C1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O |
| TCMBANKIN058347 | WLN: R2R | 103-29-7; AB-131/40879352; sym-Diphenylethane; 39660-70-3; Benzene, 1,1'-(1,2-ethanediyl)bis-; EINECS 203-096-4; NSC 30686; 2-phenylethylbenzene; Ethane, 1,2-diphenyl-; ST5406346; NSC30686; 1,2-Diphenylethane; NSC8789; Dihydrostilbene; 1,2-Dihydrostilbene; ZINC01000250; Bibenzyl; 14330_FLUKA; Dibenzyl; ghl.PD_Mitscher_leg0.651; 1,2-Diphenylethane, s; InChI=1/C14H14/c1-3-7-13(8-4-1)11-12-14-9-5-2-6-10-14/h1-10H,11-12H; B33706_ALDRICH; s-Diphenylethane; 1,1'-ethane-1,2-diyldibenzene; Dibenzil; Diphenylethylene; C14685; AI3-06161; Bibenzyl | C14H14 | 182.26 g/mol | C1=CC=C(C=C1)CCC2=CC=CC=C2 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab